Could a safer drug replace magnesium for seizure prevention in pregnancy?
NCT ID NCT07220902
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether levetiracetam, a seizure medication, works as well as magnesium sulfate to prevent seizures in pregnant people with severe preeclampsia. About 1,240 participants at 32 weeks or more will be randomly assigned to one of the two drugs. The goal is to see if levetiracetam can prevent seizures with fewer side effects for both mother and baby.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECLAMPSIA PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Women's Hospital
Omaha, Nebraska, 68022, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- Genetic clues to severe preeclampsia could transform early detection
- New blood test could prevent dangerous delays in preeclampsia deliveries
- Could a simple water pill get moms home faster after severe preeclampsia?
- Promising preeclampsia drug trial halted early – what happened?
- Which IV drug tames severe preeclampsia better? labetalol vs hydralazine